Form SCHEDULE 13D/A SAB Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P. Aug 10, 2026 04:27PM
Form SCHEDULE 13D/A SAB Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P. Mar 23, 2026 04:26PM
Form SCHEDULE 13D/A SAB Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P. Mar 11, 2026 04:43PM
Form SCHEDULE 13D SAB Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P. Oct 3, 2025 04:26PM
SAB Biotherapeutics (SABS) Announces Private Placement of up to $130 Million Oct 2, 2023 07:31AM


Oct 2, 2023 07:30AM SAB Biotherapeutics Announces Private Placement of up to $130 Million to Advance Development of Lead Drug Candidate for Type 1 Diabetes